- Home
- MATH vs PMVP Comparison
MATH vs PMVP Comparison
Compare MATH & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- PMVP
- Stock Information
- Founded
- MATH 2015
- PMVP 2013
- Country
- MATH Hong Kong
- PMVP United States
- Employees
- MATH N/A
- PMVP N/A
- Industry
- MATH Finance/Investors Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- MATH Finance
- PMVP Health Care
- Exchange
- MATH Nasdaq
- PMVP Nasdaq
- Market Cap
- MATH 60.8M
- PMVP 71.9M
- IPO Year
- MATH N/A
- PMVP 2020
- Fundamental
- Price
- MATH $1.60
- PMVP $1.02
- Analyst Decision
- MATH
- PMVP Strong Buy
- Analyst Count
- MATH 0
- PMVP 3
- Target Price
- MATH N/A
- PMVP $5.33
- AVG Volume (30 Days)
- MATH 49.3K
- PMVP 136.9K
- Earning Date
- MATH 10-31-2024
- PMVP 05-08-2025
- Dividend Yield
- MATH N/A
- PMVP N/A
- EPS Growth
- MATH N/A
- PMVP N/A
- EPS
- MATH 0.17
- PMVP N/A
- Revenue
- MATH $31,399,049.00
- PMVP N/A
- Revenue This Year
- MATH N/A
- PMVP N/A
- Revenue Next Year
- MATH N/A
- PMVP N/A
- P/E Ratio
- MATH $9.59
- PMVP N/A
- Revenue Growth
- MATH 291.58
- PMVP N/A
- 52 Week Low
- MATH $0.80
- PMVP $0.82
- 52 Week High
- MATH $2.78
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- MATH 45.92
- PMVP 43.94
- Support Level
- MATH $1.47
- PMVP $0.83
- Resistance Level
- MATH $1.70
- PMVP $1.05
- Average True Range (ATR)
- MATH 0.16
- PMVP 0.11
- MACD
- MATH -0.01
- PMVP 0.01
- Stochastic Oscillator
- MATH 47.84
- PMVP 55.43
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.